Hari Padmanabhan

Hari Padmanabhan has over 15 years of experience in the field of developmental biology, currently serving as Principal Scientist at CRISPR Therapeutics since January 2017, with prior roles as Senior Scientist and Scientist within the same organization. Previous experience includes a postdoctoral fellowship at Harvard University from October 2008 to December 2016 and another postdoctoral fellowship at Massachusetts General Hospital during the same period. Hari Padmanabhan earned a PhD in Developmental Biology from Tata Institute of Fundamental Research, where studies took place from 2001 to 2008, and obtained an MSc (Hons.) in Biological Sciences from Birla Institute of Technology and Science, Pilani, from 1996 to 2001.